Nuvation Bio Inc. (NUVB): Price and Financial Metrics

Nuvation Bio Inc. (NUVB): $1.57

-0.04 (-2.48%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add NUVB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#135 of 378

in industry

NUVB Price/Volume Stats

Current price $1.57 52-week high $4.31
Prev. close $1.61 52-week low $1.52
Day low $1.56 Volume 618,468
Day high $1.63 Avg. volume 554,413
50-day MA $1.67 Dividend yield N/A
200-day MA $2.06 Market Cap 343.52M

NUVB Stock Price Chart Interactive Chart >


Nuvation Bio Inc. (NUVB) Company Bio


Nuvation Bio Inc. operates as a bio-pharmaceutical company. The Company focuses on developing oncology medicines that will improve patient lives by addressing drug resistance. Nuvation Bio serves patients worldwide.


NUVB Latest News Stream


Event/Time News Detail
Loading, please wait...

NUVB Latest Social Stream


Loading social stream, please wait...

View Full NUVB Social Stream

Latest NUVB News From Around the Web

Below are the latest news stories about NUVATION BIO INC that investors may wish to consider to help them evaluate NUVB as an investment opportunity.

Nuvation Bio Insider Ups Holding During Year \

Viewing insider transactions for Nuvation Bio Inc.'s ( NYSE:NUVB ) over the last year, we see that insiders were net...

Yahoo | May 16, 2023

Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

NEW YORK, May 04, 2023--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the first quarter ended March 31, 2023, and provided a business update.

Yahoo | May 4, 2023

12 Best Biotech Stocks To Buy Under $20

In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy Under $20. The biotechnology industry is one of the hottest sectors right now, particularly in the aftermath of the coronavirus pandemic since it was […]

Yahoo | March 21, 2023

The 7 Worst Stocks to Buy Now

With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now.

Josh Enomoto on InvestorPlace | March 18, 2023

Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

NEW YORK, March 15, 2023--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial results for the fourth quarter and full year ended December 31, 2022, and provided a business update.

Yahoo | March 15, 2023

Read More 'NUVB' Stories Here

NUVB Price Returns

1-mo -2.48%
3-mo -15.14%
6-mo -20.71%
1-year N/A
3-year N/A
5-year N/A
YTD -18.23%
2022 -77.41%
2021 -27.35%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!